Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC-1 Alone and with ACE Inhibitor in Hypertensive Type 2 Diabetes
NCT00157729Phase 2Completed
- Sponsor
- Medicure Inc.
- Start
- Aug 2004
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pyridoxal-5'-phosphate in hypertension (HTN), type 2 diabetes mellitus (T2DM), sponsored by Medicure Inc.. Started Aug 2004; status: completed.
02
Drugs
pyridoxal-5'-phosphate
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00157729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157729.